JNJ

235

+0.38%↑

UNH

279.8

-2.1%↓

TMO

574.35

-2.08%↓

ISRG

474.85

-3.75%↓

ABT

108.42

+0.56%↑

JNJ

235

+0.38%↑

UNH

279.8

-2.1%↓

TMO

574.35

-2.08%↓

ISRG

474.85

-3.75%↓

ABT

108.42

+0.56%↑

JNJ

235

+0.38%↑

UNH

279.8

-2.1%↓

TMO

574.35

-2.08%↓

ISRG

474.85

-3.75%↓

ABT

108.42

+0.56%↑

JNJ

235

+0.38%↑

UNH

279.8

-2.1%↓

TMO

574.35

-2.08%↓

ISRG

474.85

-3.75%↓

ABT

108.42

+0.56%↑

JNJ

235

+0.38%↑

UNH

279.8

-2.1%↓

TMO

574.35

-2.08%↓

ISRG

474.85

-3.75%↓

ABT

108.42

+0.56%↑

Search

Quanterix Corp

Închisă

SectorSănătate

6.14 -7.53

Rezumat

Modificarea prețului

24h

Curent

Minim

6.32

Maxim

6.79

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+15.38% upside

Dividende

By Dow Jones

Următoarele câștiguri

16 mar. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

66M

304M

Deschiderea anterioară

13.67

Închiderea anterioară

6.14

Sentimentul știrilor

By Acuity

50%

50%

152 / 352 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 feb. 2026, 23:11 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

3 feb. 2026, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3 feb. 2026, 23:50 UTC

Market Talk

Nikkei May Decline After Hitting All-Time High -- Market Talk

3 feb. 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

3 feb. 2026, 23:41 UTC

Achiziții, Fuziuni, Preluări

KKR Makes AI Play With $10.9B Asia Data-Center Deal

3 feb. 2026, 23:38 UTC

Câștiguri

AMD Sales Climb on Help From Data-Center Business -- Update

3 feb. 2026, 23:29 UTC

Achiziții, Fuziuni, Preluări

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

3 feb. 2026, 23:27 UTC

Achiziții, Fuziuni, Preluări

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

3 feb. 2026, 23:25 UTC

Achiziții, Fuziuni, Preluări

KKR-Consortium Expects Deal to Close by Early 2H of 2026

3 feb. 2026, 23:23 UTC

Achiziții, Fuziuni, Preluări

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

3 feb. 2026, 23:22 UTC

Achiziții, Fuziuni, Preluări

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

3 feb. 2026, 23:19 UTC

Market Talk

Australia Gold Miners Tipped to Rally Higher -- Market Talk

3 feb. 2026, 23:19 UTC

Market Talk

Global Equities Roundup: Market Talk

3 feb. 2026, 22:56 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

3 feb. 2026, 22:40 UTC

Câștiguri

Amdocs Extends Collaboration With T-Mobile

3 feb. 2026, 22:39 UTC

Câștiguri

Amdocs 1Q Adj EPS $1.81

3 feb. 2026, 22:39 UTC

Câștiguri

Amdocs 1Q Rev $1.16B

3 feb. 2026, 22:39 UTC

Câștiguri

Amdocs 1Q EPS $1.45 >

3 feb. 2026, 22:38 UTC

Câștiguri

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

3 feb. 2026, 22:30 UTC

Achiziții, Fuziuni, Preluări

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

3 feb. 2026, 22:22 UTC

Achiziții, Fuziuni, Preluări

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

3 feb. 2026, 22:14 UTC

Câștiguri

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

3 feb. 2026, 22:13 UTC

Câștiguri

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

3 feb. 2026, 22:12 UTC

Câștiguri

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

3 feb. 2026, 22:10 UTC

Câștiguri

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

3 feb. 2026, 22:10 UTC

Câștiguri

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

3 feb. 2026, 22:10 UTC

Market Talk

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

3 feb. 2026, 22:10 UTC

Câștiguri

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

3 feb. 2026, 22:09 UTC

Câștiguri

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

3 feb. 2026, 22:09 UTC

Câștiguri

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

15.38% sus

Prognoză pe 12 luni

Medie 7.5 USD  15.38%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

152 / 352 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat